期刊文献+

非小细胞肺癌组织中p16基因表达的意义 被引量:1

Expression and Significance of p16 Gene Protein in Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的探讨p16基因蛋白在人非小细胞肺癌组织中的表达情况。方法应用免疫组化SP法检测45例非小细胞肺癌组织、21例肺良性疾病组织中p16基因蛋白的表达情况。结果肺良性疾病中p16蛋白阳性率85.7%,高于肺癌组织的51.1%,差异有统计学意义(P=0.004);p16蛋白表达阳性率肺癌Ⅰ、Ⅱ期高于Ⅲ、Ⅳ期,无淋巴结转移者高于有淋巴结转移者(P<0.05)。结论p16基因蛋白的表达情况与非小细胞肺癌的发生、发展有关。 Objective To investigate the expression of p16 gene protein in non-small cell lung cancer. Methods With SP immunohistochemistry, tissue of 21 cases of lung benign diseases and 45 of non-small cell lung cancer were stained by using the monoclonal antibody against the human p16 protein. Results Expression of p16 gene protein was observed in 85.7% of normal tissues,while 51.1% of lung cancer tissues showed p16 gene protein expression (P = 0. 004). The expression of p16 protein positive rate was significantly correlated with the clinical stage ( Ⅰ , Ⅱ stage was higher than Ⅲ, Ⅳ stage) and the lymph node metastasis was lower than the non one (P 〈 0. 05). Conclusion Expression of p16 protein was related to the carcinogenesis and development of lung cancer.
出处 《广西医学》 CAS 2009年第6期776-778,共3页 Guangxi Medical Journal
基金 广西科学基金(桂科自0542078)
关键词 非小细胞肺癌 免疫组织化学 P16蛋白表达 Non-small cell lung cancer Immunohistochemistry p16 protein expression
  • 相关文献

参考文献3

二级参考文献73

  • 1黄东宁,宁四海.局部晚期非小细胞肺癌联合放化疗疗效观察[J].广西医学,2005,27(4):512-513. 被引量:3
  • 2彭楠,黄英才.高温并药物治疗肿瘤的机制及常用药物[J].中华理疗杂志,1995,18(2):111-114. 被引量:26
  • 3Venkataraman G M, gi Yatin, R Marcinek and K B Ain. Restoration of iodide uptake in dedifferentiated thyroid carcinoma:relationship to human Na+/I-symporter gene methylation status. J Clin Endocrinol Metab 1999; 84(7):2449-57.
  • 4Cui J, L R Rohr, G Swanson, V O Speights, T Maxwell and A R Brothman. Hypermethylation of the caveolin- 1 gene promoter in prostate cancer. Prostate 2001: 46(3):249-56.
  • 5Toyota M, C Ho, N Ahuja, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59(10):2307-12.
  • 6Ferlay J, F Bray, P Pisani and D M Parkin. GOBOCAB 2000 Cancer Incidence, Mortality and Prevalence Worldwide,. Lyon:IARC Scienctific Publications, IARC Press, 2001.
  • 7Parkin D, P Pisani and J Ferlay. Global cancer statistics. CA Cancer J. Clin., 1999; 49:33-64.
  • 8Cancer Incidence and Mortality in China, 1993-1997 (Selected Cities and Counties). Beijing: China Publishing House of Medical Sciences and Technologies, 1998.
  • 9Feitelson M A, B Sun, N L Satiroglu Tufan, J Liu, J Pan and Z Lian. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21(16):2593-604.
  • 10Kim J W and X W Wang. Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?Carcinogenesis 2003; 24(3):363-9.

共引文献53

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部